ORASURE TECHNOLOGIES INC — fact timeline

ORASURE TECHNOLOGIES INC: Amendment to declassify the board of directors over a three-year period beginning at the fiscal 2027 annual meeting, so that all directors will be elected annually (effective 2026-06-03).

“As further described in Item 5.07 to this Current Report on Form 8-K, at the Annual Meeting, the stockholders of the Company approved an amendment (the “Amendment”) to the Company’s Certificate of Incorporation to declassify the Company’s board of directors (the “Board of Directors”) over a three-year period, beginning at the fiscal 2027 annual meeting of stockholders, such that from and after the fiscal 2027 annual meeting, all directors who are up for election at an annual meeting of stockholders will be elected to serve for a term of one year and until such directors’ successors are duly elected and qualified or until such directors’ earlier death, resignation or removal. On June 3, 2026, the Company filed a Certificate of Amendment to the Company’s Certificate of Incorporation (the “Certificate of Amendment”) with the Secretary of State of the State of Delaware and the Certificate of Amendment became effective on filing.”

ORASURE TECHNOLOGIES INC shareholders approved Amendment to the Company’s Certificate of Incorporation to Declassify the Board of Directors and Add Certain Clarifying Changes at the 2026-06-03 meeting.

“ITEM 5 . Amendment to the Company’s Certificate of Incorporation to Declassify the Board of Directors and Add Certain Clarifying Changes Votes For Votes Against Abstentions Broker Non-Votes 49,125,748 2,223,960 117,452 10,579,208”

ORASURE TECHNOLOGIES INC shareholders approved Approval of an Amendment and Restatement of the Stock Award Plan to Increase the Shares Authorized For Issuance Thereunder at the 2026-06-03 meeting.

“ITEM 4 . Approval of an Amendment and Restatement of the Stock Award Plan to Increase the Shares Authorized For Issuance Thereunder. Votes For Votes Against Abstentions Broker Non-Votes 57,055,163 4,796,974 194,231 0”

ORASURE TECHNOLOGIES INC shareholders approved Advisory (Non-Binding) Vote to Approve the Resolution on the Company’s Executive Compensation at the 2026-06-03 meeting.

“ITEM 3. Advisory (Non-Binding) Vote to Approve the Resolution on the Company’s Executive Compensation. Votes For Votes Against Abstentions Broker Non-Votes 45,225,131 6,179,090 62,939 10,579,208”

ORASURE TECHNOLOGIES INC shareholders approved Ratification of the Appointment of Grant Thornton LLP as the Company’s Independent Registered Public Accounting Firm for Fiscal Year 2026 at the 2026-06-03 meeting.

“ITEM 2 . Ratification of the Appointment of Grant Thornton LLP as the Company’s Independent Registered Public Accounting Firm for Fiscal Year 2026. Votes For Votes Against Abstentions 59,891,739 2,143,244 11,385”

ORASURE TECHNOLOGIES INC shareholders approved Election of Three Class II Directors for Terms Ending in 2029 at the 2026-06-03 meeting.

“ITEM 1 . Election of Three (3) Class II Directors for Terms Ending in 2029. NAME Votes For Votes Against Abstentions Broker Non-Votes John D. Bertrand 47,822,139 3,366,544 278,477 10,579,208 Steven K. Boyd 48,806,872 2,596,468 63,820 10,579,208 Robert W. McMahon 47,770,768 3,583,027 113,365 10,579,208”

ORASURE TECHNOLOGIES INC reported financial results for the quarter ended March 31, 2026.

“On May 6, 2026, OraSure Technologies, Inc. (the “Company”) issued a press release announcing its consolidated financial results for the quarter ended March 31, 2026”

ORASURE TECHNOLOGIES INC entered into Cooperation Agreement with Altai Capital Management, L.P. and Altai Capital Management, LLC (collectively, Altai) (effective 2026-04-16).

“On April 16, 2026, OraSure Technologies, Inc. (the “Company”) announced its entry into a cooperation agreement (the “Cooperation Agreement”) with Altai Capital Management, L.P. and Altai Capital Management, LLC (collectively, “Altai”).”

Kathleen G. Weber resigned as Chief Product Officer at ORASURE TECHNOLOGIES INC.

“On May 8, 2025, Kathleen G. Weber notified OraSure Technologies, Inc. (the “Company”) of her resignation as Chief Product Officer of the Company, effective June 30, 2025.”

John P. Kenny was appointed as Director at ORASURE TECHNOLOGIES INC.

“the Board appointed John P. Kenny as a new member of the Board, with such appointment to be effective as of the Effective Date.”

ORASURE TECHNOLOGIES INC: Amendment to Certificate of Incorporation to limit officer liability, as permitted by recent Delaware law amendments (effective 2024-05-16).

“As further described in Item 5.07 to this Current Report on Form 8-K, at the Annual Meeting, the stockholders of the Company approved an amendment (the “Amendment”) to the Company’s Certificate of Incorporation to limit the liability of certain officers of the Company as permitted by recent amendments to Delaware law. On May 16, 2024, the Company filed a Certificate of Amendment to the Company’s Certificate of Incorporation (the “Certificate of Amendment”) with the Secretary of State of the State of Delaware and the Certificate of Amendment became effective on filing.”

ORASURE TECHNOLOGIES INC shareholders approved Approval to Adjourn the Annual Meeting to a Later Date or Dates at the 2024-05-14 meeting.

“ITEM 6 . Approval to Adjourn the Annual Meeting to a Later Date or Dates, If Necessary or Appropriate, to Permit Further Solicitation and Vote of Proxies in the Event That There are Insufficient Votes for, or Otherwise, in Connection with the Approval of the Foregoing Proposals. Votes For Votes Against Abstentions 50,515,683 16,580,420 33,979”

ORASURE TECHNOLOGIES INC shareholders approved Approval of an Amendment and Restatement of the Stock Award Plan to Increase the Shares Authorized for Issuance Thereunder at the 2024-05-14 meeting.

“ITEM 5 . Approval of an Amendment and Restatement of the Stock Award Plan to Increase the Shares Authorized for Issuance Thereunder. Votes For Votes Against Abstentions Broker Non-Votes 56,999,751 5,034,883 88,291 5,007,157”

ORASURE TECHNOLOGIES INC shareholders approved Approval of an amendment to the Company's Certificate of Incorporation at the 2024-05-14 meeting.

“ITEM 4 . Approval of an amendment to the Company's Certificate of Incorporation. Votes For Votes Against Abstentions Broker Non-Votes 54,132,675 7,945,995 44,255 5,007,157”

ORASURE TECHNOLOGIES INC shareholders approved Advisory (Non-Binding) Vote to Approve the Resolution on the Company's Executive Compensation at the 2024-05-14 meeting.

“ITEM 3. Advisory (Non-Binding) Vote to Approve the Resolution on the Company's Executive Compensation. Votes For Votes Against Abstentions Broker Non-Votes 57,538,779 4,472,675 111,471 5,007,157”

ORASURE TECHNOLOGIES INC shareholders approved Ratification of the Appointment of Grant Thornton LLP as the Company's Independent Registered Public Accounting Firm for Fiscal Year 2024 at the 2024-05-14 meeting.

“ITEM 2 . Ratification of the Appointment of Grant Thornton LLP as the Company's Independent Registered Public Accounting Firm for Fiscal Year 2024. Votes For Votes Against Abstentions 64,912,239 2,158,172 59,671”

ORASURE TECHNOLOGIES INC shareholders approved Election of two Class III Directors for Terms Ending in 2027 at the 2024-05-14 meeting.

“ITEM 1 . Election of two Class III Directors for Terms Ending in 2027. NAME Votes For Votes Against Abstentions Broker Non-Votes Nancy J. Gagliano, M.D. 57,243,711 4,832,639 46,575 5,007,157 Lelio Marmora 57,332,773 4,732,865 57,287 5,007,157”

ORASURE TECHNOLOGIES INC reported financial results for quarter ended March 31, 2024.

“On May 8, 2024, OraSure Technologies, Inc. (the “Company”) issued a press release announcing its consolidated financial results for the quarter ended March 31, 2024 and certain other matters.”

ORASURE TECHNOLOGIES INC reported financial results for the full year and quarter ended December 31, 2023.

“OraSure Technologies, Inc. (the “Company”) issued a press release announcing its consolidated financial results for the full year and quarter ended December 31, 2023 and certain other matters.”